arrow-left  #dr.-reddy's-labs-q3

Article Image
     
  • 05 March, 2024 |
  •  
  • 10:03 AM

The consolidated income from operations grew by roughly 14% year-on-year to ₹159 Crore.

Read More

More News

ALL #dr.-reddy's-labs-q3
Article Image
  • The consolidated income from operations grew by roughly 14% year-on-year to ₹159 Crore.
  • |
  • IIFL News Service |
  • 05 March, 2024 |
  • 12:23 AM
Image not found
  • The complaint alleges Dr Reddy's "improperly restrained competition" and maintained a monopoly for the cancer drug Revlimid.
  • |
  • IIFL News Service |
  • 01 March, 2024 |
  • 12:18 AM
Image not found
  • The Mohali facility has been under USFDA scrutiny, and corrective actions were directed by the regulator.
  • |
  • IIFL News Service |
  • 26 February, 2024 |
  • 12:12 AM
Image not found
  • Companies invested the incremental gross profit in their marketing spend in Q3 keeping festive season in mind.
  • |
  • IIFL News Service |
  • 21 February, 2024 |
  • 12:04 AM
ad IconAd Image